Cytek Biosciences, Inc. Common Stock Share Price
NASDAQ: CTKBHealthcare
Live Cytek Biosciences, Inc. Common Stock Share Price Chart
O H L
Cytek Biosciences, Inc. Common Stock Performance Overview
Days Range
▼
$5.09Low
$5.25High
Markets Today
| Previous Close | $5.21 |
|---|---|
| Open | $5.09 |
| Volume | 152,081 |
| Day's Range | $5.09 - $5.25 |
| 52W Range | $3.28 - $6.18 |
| Market Cap | $640.82 M |
Historical Performance
| 1M Returns | +11.56 |
|---|---|
| 3M Returns | +38.20 |
| 6M Returns | +20.05 |
| 1Y Returns | +27.38 |
| 5Y Returns | -79.93 |
| 10Y Returns | NA |
Cytek Biosciences, Inc. Common Stock Fundamentals
| Market Cap | $640.82 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $201.49 M |
| ROE TTM | -0.18 |
| EPS TTM | $-0.63 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.99 |
| EBITDA | $-32.80 M |
| Profit Margin | -33.02 |
| Market Cap | $640.82 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $201.49 M |
| ROE TTM | -0.18 |
| EPS TTM | $-0.63 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.99 |
| EBITDA | $-32.80 M |
| Profit Margin | -33.02 |
Cytek Biosciences, Inc. Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $41.46 M | $45.60 M | $52.29 M | $62.14 M | $44.13 M | $48.14 M |
| Gross Profit + | $20.16 M | $23.87 M | $27.55 M | $32.88 M | $21.25 M | $28.34 M |
| Operating Income | -$14.97 M | -$10.62 M | -$9.19 M | -$5.59 M | -$18.46 M | -$11.40 M |
| EBITDA | -$13.10 M | -$8.73 M | -$7.27 M | -$3.70 M | -$16.60 M | -$9.39 M |
| Interest Expense | -$291.00 K | -$414.00 K | -$494.00 K | $725.00 K | -$262.00 K | -$281.00 K |
| Depreciation | $1.88 M | $1.89 M | $1.92 M | $1.90 M | $1.86 M | $2.01 M |
| Income Before Tax | -$11.27 M | -$6.78 M | -$7.77 M | -$4.03 M | -$17.37 M | -$11.64 M |
| Income Tax Expense | $136.00 K | -$1.19 M | -$2.29 M | $40.05 M | $1.49 M | $515.00 K |
| Net Income + | -$11.40 M | -$5.58 M | -$5.48 M | -$44.08 M | -$18.87 M | -$12.16 M |
| Net Profit Margin | -27.5% | -12.24% | -10.48% | -70.93% | -42.75% | -25.26% |
Cytek Biosciences, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $128.00 K | $127.00 K | $128.00 K | $129.00 K | $129.00 K | $130.00 K |
| Reserve & Surplus | -$47.21 M | -$52.22 M | -$56.84 M | -$99.50 M | -$118.23 M | -$130.02 M |
| Non-Current Liabilities | $35.28 M | $42.49 M | $41.14 M | $42.00 M | $40.53 M | $40.65 M |
| Current Liabilities | $67.69 M | $73.27 M | $75.21 M | $77.80 M | $80.94 M | $84.33 M |
| Total Liabilities | $102.97 M | $115.76 M | $116.35 M | $119.80 M | $121.47 M | $124.98 M |
| Fixed Assets | $37.27 M | $36.95 M | $35.72 M | $34.83 M | $36.17 M | $35.67 M |
| Current Assets | $380.50 M | $382.82 M | $388.49 M | $392.00 M | $379.30 M | $377.93 M |
| Total Assets | $482.60 M | $493.32 M | $494.92 M | $461.54 M | $449.11 M | $446.93 M |
Cytek Biosciences, Inc. Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$11.40 M | -$5.58 M | -$5.48 M | -$44.08 M | -$18.87 M | -$12.16 M |
| Operating Cash Flow | -$125.00 K | $108.00 K | -$3.90 M | -$771.00 K | -$2.74 M | $1.37 M |
| Investing Cash Flow | $9.45 M | -$16.41 M | $18.92 M | -$1.84 M | -$27.08 M | $7.02 M |
| Financing Cash Flow | -$11.54 M | -$2.60 M | $1.94 M | -$1.23 M | $3.98 M | -$814.00 K |
| Change in Cash | -$3.45 M | -$19.83 M | $17.81 M | -$2.43 M | -$25.19 M | $8.18 M |
Cytek Biosciences, Inc. Common Stock Return Calculator
The Cytek Biosciences, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$1,992
Invested Amount$10,000
Est. Returns$-8,008
About Cytek Biosciences, Inc. Common Stock
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.
Popular Stocks
FAQs
What is the share price of Cytek Biosciences, Inc. Common Stock today?
Cytek Biosciences, Inc. Common Stock (CTKB) share price as of September 18, 2026 is $5.17. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Cytek Biosciences, Inc. Common Stock?
Yes, Indian Investors can invest in the Cytek Biosciences, Inc. Common Stock (CTKB) Share by opening an international trading account with Angel One.
How can I purchase Cytek Biosciences, Inc. Common Stock shares in India?
Purchasing Cytek Biosciences, Inc. Common Stock (CTKB) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Cytek Biosciences, Inc. Common Stock (CTKB) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Cytek Biosciences, Inc. Common Stock?
Yes, you can purchase fractional shares of Cytek Biosciences, Inc. Common Stock (CTKB) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Cytek Biosciences, Inc. Common Stock?
The market capitalization of Cytek Biosciences, Inc. Common Stock on September 18, 2026, is $640.82 M.
In which sector Cytek Biosciences, Inc. Common Stock belongs?
Cytek Biosciences, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Cytek Biosciences, Inc. Common Stock stocks?
In order to invest in Cytek Biosciences, Inc. Common Stock (CTKB) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
